1 study on AMP-X1 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research represents a significant breakthrough in leveraging AI for drug discovery, offering a powerful new approach to combat the escalating crisis of antimicrobial resistance. The successful design and in vitro…
Free, no account — handy when you're working with AMP-X1.